Multiplexed digital assays with combinatorial use of signals
US-9222128-B2 · Dec 29, 2015 · US
US12454718B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12454718-B2 |
| Application number | US-202217574780-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 13, 2022 |
| Priority date | Feb 12, 2010 |
| Publication date | Oct 28, 2025 |
| Grant date | Oct 28, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.
Opening claim text (preview).
What is claimed is: 1 . A method for detecting targets, the method comprising: partitioning a sample comprising at least a first and a second nucleic acid target into a plurality of compartments, wherein one or more of the compartments comprise primers and probes that include a first primer pair specific for the first nucleic acid target, a second primer pair specific for the second nucleic acid target, a first probe that fluoresces when the first nucleic acid target is amplified, and a second probe that fluoresces when the second nucleic acid target is amplified, wherein (i) the first primer pair and the second primer pair are present in the one or more compartments at different concentrations, (ii) the first and the second probe are present in the one or more compartments at different concentrations, or (iii) the first primer pair and the second primer pair are present in the one or more compartments at different concentrations and the first probe and the second probe are present in the one or more compartments at different concentrations; thermocycling the plurality of compartments; detecting fluorescence of one color from one or both of the first probe and the second probe in the one or more of the compartments; and creating a plot showing distinct clusters of compartments having the one color, each distinct cluster representing compartments that contain one or both of the first and second nucleic acid targets, and detecting presence or absence of each of the first and second nucleic acid targets in the one or more of the compartments. 2 . The method of claim 1 , further comprising quantifying each of the first and second nucleic acid targets in the sample. 3 . The method of claim 2 , wherein the quantifying step comprises counting positive compartments for each of the first and second nucleic acid targets. 4 . The method of claim 1 , further comprising diluting the sample prior to the partitioning step. 5 . The method of claim 4 , wherein the diluting step results in most of the plurality of compartments comprising no more than one nucleic acid molecule. 6 . The method of claim 1 , wherein the detecting flouroescence comprises optically detecting. 7 . The method of claim 1 , wherein the first and second probes are distinct fluorescent probes. 8 . The method of claim 1 , wherein the first probe and the second probe are each labeled with a flourophore having the one color. 9 . The method of claim 1 , wherein the thermocycling step generates amplicons comprising copies of the targets. 10 . The method of claim 1 , wherein the first and second probes are fluorescent probes that hybridize to amplicons and fluoresce during or after the thermocycling step. 11 . The method of claim 1 , wherein each probe comprises a fluorescent dye and binds specifically to a target or amplified copy of the target. 12 . The method of claim 1 , wherein the plot shows intensity of the one color on one axis. 13 . The method of claim 1 , wherein the detecting fluroescence step comprises detecting flouroescence intensity of the one color from one or more of the compartments. 14 . The method of claim 1 , wherein the compartments are droplets and the partitioning step comprises flowing a first fluid and a second fluid into a microfluidic droplet generator, wherein the first fluid comprises the sample and the second fluid comprises an oil immiscible with the sample. 15 . The method of claim 14 , wherein two channels intersect at an intersection within the droplet generator, wherein the first fluid and the second fluid converge at the intersection and form the droplets. 16 . The method of claim 1 , wherein the first probe and the second probe are labeled with the one color.
Polymerase chain reaction [PCR] · CPC title
Haplotypes · CPC title
for cancer (immunoassay for cancer G01N33/575) · CPC title
for diseases caused by alterations of genetic material · CPC title
for detection of mutation or polymorphism · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.